サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1748823

イブプロフェン市場 - 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、用途別、地域別、競合別、2020年～2030年

Ibuprofen Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 185 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.92円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

イブプロフェン市場 - 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、用途別、地域別、競合別、2020年～2030年
出版日: 2025年06月13日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

イブプロフェンの世界市場は、2024年に5億3,445万米ドルと評価され、2030年までには7億3万米ドルに達し、CAGR4.80%で成長すると予測されています。

非ステロイド性抗炎症薬（NSAID）として広く使用されているイブプロフェンは、関節炎、月経痛、歯科疾患、風邪など様々な治療領域において、疼痛、発熱、炎症の管理に手頃な価格と有効性が認められています。錠剤、カプセル剤、シロップ剤、外用剤など様々な剤形があり、入手しやすいことから、処方薬としても市販薬としてもよく使われる治療薬となっています。同市場の成長を牽引しているのは、特に高齢者層における慢性疼痛と加齢性疾患の増加です。世界的に平均寿命が延びるにつれ、安全で信頼性が高く、費用対効果の高い鎮痛薬に対する需要も高まっています。競合情勢は非常に厳しく、多くの世界企業や地域企業が原薬（API）生産と最終製剤開発の両方に携わっており、価格動向に敏感な市場環境となっています。

市場概要
予測期間 2026年～2030年
市場規模：2024年 5億3,445万米ドル
市場規模：2030年 7億3万米ドル
CAGR：2025年～2030年 4.80%
急成長セグメント 錠剤
最大市場 北米

主要な市場促進要因

ヘルスケア産業の成長

主要な市場課題

安全性と副作用への懸念

主要市場動向

電子薬局の拡大

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のイブプロフェン市場にCOVID-19が与える影響

第5章 世界のイブプロフェン市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 製品タイプ別（錠剤、カプセル、シロップ、注射剤）
    • 用途別（関節リウマチ、強直性脊椎炎、炎症性疾患、月経困難症、その他）
    • 地域別
    • 企業別（2024年）
  • 市場マップ

第6章 北米のイブプロフェン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州のイブプロフェン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋のイブプロフェン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米のイブプロフェン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのイブプロフェン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収
  • 製品上市
  • 最近の動向

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 世界のイブプロフェン市場：SWOT分析

第15章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第16章 競合情勢

  • Novartis AG
  • Pfizer Inc.
  • Abbott Laboratories Inc.
  • Gilead Sciences Inc.
  • Merck KGaA
  • Astellas Pharma Inc.
  • Glenmark Pharmaceuticals Ltd.
  • NATCO Pharma Ltd.
  • Basilea Pharmaceutical AG
  • Leadiant Biosciences Inc.

第17章 戦略的提言

第18章 調査会社について・免責事項

目次
Product Code: 7235

The Global Ibuprofen Market was valued at USD 534.45 Million in 2024 and is projected to reach USD 700.03 Million by 2030, growing at a CAGR of 4.80%. Ibuprofen, a widely used nonsteroidal anti-inflammatory drug (NSAID), is recognized for its affordability and effectiveness in managing pain, fever, and inflammation across various therapeutic areas including arthritis, menstrual cramps, dental issues, and the common cold. Available in several formulations such as tablets, capsules, syrups, and topical applications, ibuprofen's accessibility makes it a go-to treatment option for both prescription and over-the-counter use. The market's growth is driven by the increasing incidence of chronic pain and age-related disorders, particularly in the elderly population. As life expectancy rises globally, so does the demand for safe, reliable, and cost-effective analgesics. The manufacturing landscape is highly competitive, with numerous global and regional players engaged in both active pharmaceutical ingredient (API) production and finished dosage development, contributing to a price-sensitive market environment.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 534.45 Million
Market Size 2030USD 700.03 Million
CAGR 2025-20304.80%
Fastest Growing SegmentTablet
Largest MarketNorth America

Key Market Drivers

Growth in Healthcare Industry

The sustained expansion of the global healthcare industry is a key driver of the ibuprofen market. The U.S. alone spends nearly USD 3.5 trillion annually on healthcare, while healthcare expenditure in Europe comprises around 12% of GDP. In contrast, BRIC nations allocate an average of 6% of GDP to health services. This growing investment in healthcare infrastructure, combined with improved access to treatment and the increasing emphasis on affordable care, supports rising demand for over-the-counter and prescription medications like ibuprofen. Known for its anti-inflammatory, analgesic, and fever-reducing effects, ibuprofen remains a trusted first-line treatment option for mild to moderate pain and inflammatory conditions. Companies such as IOL Chemicals and Pharmaceuticals, which supplies about one-third of the global ibuprofen API, are expanding their product portfolios to meet growing demand fueled by the rising prevalence of lifestyle-related ailments like arthritis, chronic headaches, and musculoskeletal disorders.

Key Market Challenges

Safety & Side Effect Concerns

Despite its widespread usage and therapeutic benefits, ibuprofen faces notable challenges due to safety concerns and potential side effects. As an NSAID, ibuprofen is linked to gastrointestinal issues, particularly when used at high doses or over extended periods. Common side effects include stomach irritation, ulcers, and bleeding, which pose heightened risks for elderly patients or individuals with pre-existing GI conditions. In response, healthcare providers are increasingly recommending alternative treatments or co-prescribing gastroprotective agents to mitigate these risks. This shift in prescribing behavior could dampen demand for ibuprofen and encourage the use of other analgesic options, especially in vulnerable patient populations.

Key Market Trends

Expansion of E-Pharmacy

The growing prominence of e-pharmacy platforms is reshaping the global ibuprofen market by revolutionizing how medications are purchased and delivered. With digital transformation accelerating across the healthcare sector, online pharmacies are gaining traction as a preferred distribution channel for OTC medications like ibuprofen. Companies such as Amazon, Reliance, Tata 1mg, and PharmEasy are scaling operations in response to rising demand for convenience, competitive pricing, and timely access to medicines. In India, the e-pharmacy market was expected to expand sevenfold to USD 2.7 billion by 2023, reflecting broader shifts in consumer behavior and increased internet accessibility. This trend is enhancing market penetration, particularly in underserved regions, while also intensifying competition among digital pharmacy players seeking to dominate this growing segment.

Key Market Players

  • Novartis AG
  • Pfizer Inc.
  • Abbott Laboratories Inc.
  • Gilead Sciences Inc.
  • Merck KGaA
  • Astellas Pharma Inc.
  • Glenmark Pharmaceuticals Ltd.
  • NATCO Pharma Ltd.
  • Basilea Pharmaceutical AG
  • Leadiant Biosciences Inc.

Report Scope

In this report, the Global Ibuprofen Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ibuprofen Market, By Product Type:

  • Tablet
  • Capsule
  • Syrup
  • Injection

Ibuprofen Market, By Application:

  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Inflammatory Diseases
  • Dysmenorrhea
  • Others

Ibuprofen Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ibuprofen Market.

Available Customizations

Global Ibuprofen Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Ibuprofen Market

5. Global Ibuprofen Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Tablet, Capsule, Syrup, Injection)
    • 5.2.2. By Application (Rheumatoid Arthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Ibuprofen Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Ibuprofen Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Mexico Ibuprofen Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Canada Ibuprofen Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application

7. Europe Ibuprofen Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Ibuprofen Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Ibuprofen Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Ibuprofen Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Ibuprofen Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Ibuprofen Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Ibuprofen Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Ibuprofen Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Ibuprofen Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
    • 8.3.3. South Korea Ibuprofen Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
    • 8.3.4. Japan Ibuprofen Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Ibuprofen Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application

9. South America Ibuprofen Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Ibuprofen Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Ibuprofen Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Ibuprofen Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Ibuprofen Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Ibuprofen Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Ibuprofen Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Ibuprofen Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Ibuprofen Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Novartis AG
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. Pfizer Inc.
  • 16.3. Abbott Laboratories Inc.
  • 16.4. Gilead Sciences Inc.
  • 16.5. Merck KGaA
  • 16.6. Astellas Pharma Inc.
  • 16.7. Glenmark Pharmaceuticals Ltd.
  • 16.8. NATCO Pharma Ltd.
  • 16.9. Basilea Pharmaceutical AG
  • 16.10. Leadiant Biosciences Inc.

17. Strategic Recommendations

18. About Us & Disclaimer